UCA1 and colorectal carcinoma: While EV-UCA1 has been reported to be elevated in Controls compared to CRC patients, Yang et al. showed that EV-UCA1 levels increase upon cetuximab-resistant CRC as evidenced both in vitro and in CRC patients under cetuximab therapy.167